| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/20/2009 | US20090209458 Cell-penetrating socs polypeptides that inhibit cytokine-induced signaling |
| 08/20/2009 | US20090209455 Vitreous administration of erythropoietin |
| 08/20/2009 | US20090209453 Glycoprotein Hormone Analogs |
| 08/20/2009 | US20090209437 Temperature regulated promoters from schizosaccharomyces pombe for expression of proteins |
| 08/20/2009 | US20090209041 Peptides and methods for inhibiting amyloid formation |
| 08/20/2009 | US20090209037 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/20/2009 | US20090209034 Tumour rejection antigens |
| 08/20/2009 | US20090209033 Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity |
| 08/20/2009 | US20090209006 Taci-immunoglobulin fusion proteins |
| 08/20/2009 | US20090209003 Mutant pcna |
| 08/20/2009 | US20090209002 Compositions and methods relating to cellular targeting |
| 08/20/2009 | US20090209000 Genetically Programmed Expression of Proteins |
| 08/20/2009 | US20090208998 D/p creatinine marker, method of determining d/p creatinine, and intended use thereof |
| 08/20/2009 | US20090208993 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof |
| 08/20/2009 | US20090208974 Human Neuronal Attachment Factor-1 |
| 08/20/2009 | US20090208972 Cytotoxic protein and utlization thereof |
| 08/20/2009 | US20090208970 Probe for detection and quantification of inositol-1,4,5-trisphosphate and a method for detecting and quantifying inositol-1,4,5-trisphosphate using the same |
| 08/20/2009 | US20090208969 Polynucleotides and Polypeptides Encoding Receptors |
| 08/20/2009 | US20090208967 Genetic Polymorphisms As Predictive Diagnostics For Adverse Drug Reactions (ADR) And Drug Efficacy |
| 08/20/2009 | US20090208963 Gene Involved in V(D)J recombination and/or DNA repair |
| 08/20/2009 | US20090208921 Methods of detection of cancer using peptide profiles |
| 08/20/2009 | US20090208581 Formulations limiting spread of pulmonary infections |
| 08/20/2009 | US20090208565 Stabilized exendin-4 compounds |
| 08/20/2009 | US20090208538 Methods and compositions for tumor vaccination and therapy |
| 08/20/2009 | US20090208537 Anti-Neovasculature Preparations for Cancer |
| 08/20/2009 | US20090208528 Empty capsids (vlps(-vp4)) of the infectious bursal disease virus (ibdv), obtainment process and applications |
| 08/20/2009 | US20090208522 Neutralizing Epitope-Based Growth Enhancing Vaccine |
| 08/20/2009 | US20090208518 Immunogenic peptides for the treatment of prostate and breast cancer |
| 08/20/2009 | US20090208512 Catalytic anti-factor VIII allo-antibodies |
| 08/20/2009 | US20090208507 Protein isoforms and uses thereof |
| 08/20/2009 | US20090208504 Polypeptides involved in immune response |
| 08/20/2009 | US20090208498 Genetic Products Differentially Expressed In Tumors And The Use Thereof |
| 08/20/2009 | US20090208484 R-spondin compositions and methods of use thereof |
| 08/20/2009 | US20090208478 Transducible polypeptides for modifying metabolism |
| 08/20/2009 | US20090208476 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
| 08/20/2009 | US20090208462 Methods of Treatment |
| 08/20/2009 | US20090208459 Methods of treating anemia using recombinant adeno-associated virus virions |
| 08/20/2009 | US20090208458 Transcriptional inhibitor for human k-ras gene |
| 08/20/2009 | US20090208454 Modified interferon beta polypeptides and their uses |
| 08/20/2009 | US20090208452 Inhibitor of Endogenous Human Interferon-Gamma |
| 08/20/2009 | US20090208447 Polypeptides |
| 08/20/2009 | US20090208419 Multimodality Imaging of Reporter Gene Expression Using a Novel Fusion Vector in Living Cells and Animals |
| 08/20/2009 | CA2724440A1 Strategies to prevent and/or treat immune responses to soluble allofactors |
| 08/20/2009 | CA2715536A1 Cd4+ t-cells with cytolytic properties |
| 08/20/2009 | CA2715517A1 Immunogenic peptides and their use in transplantation |
| 08/20/2009 | CA2715488A1 Immunogenic control of tumours and tumour cells |
| 08/20/2009 | CA2715484A1 Elimination of immune responses to viral vectors |
| 08/20/2009 | CA2715476A1 Zea mays aba signaling genes and methods of use |
| 08/20/2009 | CA2715177A1 Hybrid polypeptides comprising gbs-80 and spb1 proteins of streptococcus |
| 08/20/2009 | CA2714128A1 Fish protein hydrolysate having a satietogenic activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
| 08/20/2009 | CA2713885A1 Novel cell lines and methods |
| 08/20/2009 | CA2711499A1 Vaccines and diagnostics for the ehrlichioses |
| 08/20/2009 | CA2705373A1 Hiv-1 envelope glycoprotein oligomer and methods of use |
| 08/20/2009 | CA2689680A1 Fc receptor-binding polypeptides with modified effector functions |
| 08/19/2009 | EP2090662A2 Process for the production of a fine chemical |
| 08/19/2009 | EP2090658A2 Generation of plants with improved pathogen resistance |
| 08/19/2009 | EP2090656A1 Mutant androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 08/19/2009 | EP2090654A1 PARTIAL FRAGMENT OF REIC/Dkk-3 GENE AND THERAPEUTIC AGENT FOR CANCER CONTAINING THE SAME |
| 08/19/2009 | EP2090650A1 Grain incomplete filling gene (gif1) and uses thereof |
| 08/19/2009 | EP2090591A2 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
| 08/19/2009 | EP2090589A1 Albumin-fused Kunitz domain peptides |
| 08/19/2009 | EP2090588A1 In vitro method for prognosis and/or diagnosis of hypersensitivity to ooestrogens or to substances with ooestrogenic activity |
| 08/19/2009 | EP2090587A1 Genes and polypeptides relating to prostate cancers |
| 08/19/2009 | EP2090586A1 Purification of her-2 variants |
| 08/19/2009 | EP2090585A1 Antigenic polypeptide usable as therapeutic agent for malignant neoplasm |
| 08/19/2009 | EP2090584A1 Identification of a novel cysteine-rich cell penetrating peptide |
| 08/19/2009 | EP2090583A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 08/19/2009 | EP2090582A2 Binding molecules for human factor VIII and factor VIII-like proteins |
| 08/19/2009 | EP2090323A1 Protein-Proteophor Complexes |
| 08/19/2009 | EP2089722A1 Biomarkers |
| 08/19/2009 | EP2089721A1 Determination of renin/prorenin receptor activity |
| 08/19/2009 | EP2089546A1 Methods of diagnosing osteoarthritis |
| 08/19/2009 | EP2089541A2 Isolated staphylococcus pseudolugdunensis |
| 08/19/2009 | EP2089521A1 Soluble tnf receptors and their use in treatment of disease |
| 08/19/2009 | EP2089513A1 Use of a varicellovirus tap-inhibitor for the induction of tumor- or virus-specific immunity against teipp |
| 08/19/2009 | EP2089427A2 Zinc finger nuclease for targeting the human glucocorticoid receptor locus |
| 08/19/2009 | EP2089426A2 Antimicrobial kinocidin compositions and methods of use |
| 08/19/2009 | EP2089425A2 Anti-angiogenic compounds |
| 08/19/2009 | EP2089424A1 Method for production of human erythropoietin |
| 08/19/2009 | EP2089423A1 Antigen specific multi epitope vaccines |
| 08/19/2009 | EP2089422A1 Methods of separating nucleic acids and protein |
| 08/19/2009 | EP2089421A1 Starch binding domain and use thereof |
| 08/19/2009 | EP2089420A2 Proteins for use in diagnosing and treating infection and disease |
| 08/19/2009 | EP2089419A2 Inhibition of beta-amyloid aggregation |
| 08/19/2009 | EP2089411A2 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 08/19/2009 | EP2089057A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 08/19/2009 | EP2089053A1 Hpv antigen fusion protein vaccine compositions and uses thereof |
| 08/19/2009 | EP1940877A4 Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings |
| 08/19/2009 | EP1824501B1 Protein hydrolysate with antidiabetic effect |
| 08/19/2009 | EP1576120B1 Bacillus subtilis for use against animal and human pathogens |
| 08/19/2009 | EP1497467B1 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof |
| 08/19/2009 | EP1470114B1 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones |
| 08/19/2009 | EP1467772B1 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor and non-tumor cells |
| 08/19/2009 | EP1446486B1 Transgenic organism expressing fungal mrp-like abc transporters |
| 08/19/2009 | EP1435360B1 Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 08/19/2009 | EP1389941B1 Alleviation of the memory deficits and memory components of psychiatric dysfunctions by altering atypical pkm activity |
| 08/19/2009 | EP1379668B1 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells |
| 08/19/2009 | EP1339425B1 Vaccine composition containing transforming growth factor alpha |
| 08/19/2009 | EP1280566B1 Growth factor modified protein matrices for tissue engineering |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |